Man Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-30,134
| Closed | -$474K | – | 2334 |
|
|
2024
Q1 | $474K | Buy |
30,134
+10,187
| +51% | +$157K | ﹤0.01% | 1800 |
|
|
2023
Q4 | $322K | Buy |
+19,947
| New | +$254K | ﹤0.01% | 1800 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1871 |
|
|
2021
Q4 | – | Sell |
-33,639
| Closed | -$1.14M | – | 2163 |
|
|
2021
Q3 | $1.14M | Sell |
33,639
-10,155
| -23% | -$324K | ﹤0.01% | 1313 |
|
|
2021
Q2 | $1.6M | Sell |
43,794
-45,072
| -51% | -$1.75M | 0.01% | 1281 |
|
|
2021
Q1 | $3.98M | Sell |
88,866
-47,910
| -35% | -$2.23M | 0.02% | 802 |
|
|
2020
Q4 | $7.81M | Sell |
136,776
-16,061
| -11% | -$952K | 0.03% | 552 |
|
|
2020
Q3 | $7.84M | Buy |
152,837
+21,762
| +17% | +$1.07M | 0.03% | 583 |
|
|
2020
Q2 | $7.83M | Buy |
131,075
+85,289
| +186% | +$4.56M | 0.04% | 459 |
|
|
2020
Q1 | $1.89M | Sell |
45,786
-7,647
| -14% | -$425K | 0.01% | 905 |
|
|
2019
Q4 | $3.33M | Buy |
53,433
+21,633
| +68% | +$1.03M | 0.01% | 1151 |
|
|
2019
Q3 | $1.08M | Buy |
+31,800
| New | +$941K | ﹤0.01% | 1411 |
|
|
2018
Q3 | – | Sell |
-2,934
| Closed | -$115K | – | 2255 |
|
|
2018
Q2 | $115K | Buy |
+2,934
| New | +$86.4K | ﹤0.01% | 2066 |
|
Other funds holding DCPH
Man Group's DCPH Position: Q2 2024 in Review
Man Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 30,134 shares — an estimated $474K sold.
Man Group first reported a position in DCPH in Q2 2018 and held it in 12 quarters. The position peaked at $7.84M in Q3 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Man Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Man Group sold 30,134 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $474K.
- Man Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 12 quarters.
- Man Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $7.84M in Q3 2020.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Man Group's 13F filing for Q2 2024, filed 14 Aug 2024.